Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17.

Zhang AY, Shrum S, Williams S, Petnic S, Nadle J, Johnston H, Barter D, VonBank B, Bonner L, Hollick R, Marceaux K, Harrison L, Schaffner W, Tesini BL, Farley MM, Pierce RA, Phipps E, Mody RK, Chiller TM, Jackson BR, Vallabhaneni S.

Clin Infect Dis. 2019 Nov 2. pii: ciz1061. doi: 10.1093/cid/ciz1061. [Epub ahead of print]

PMID:
31676903
2.

Public Health Importance of Invasive Methicillin-sensitive Staphylococcus aureus Infections: Surveillance in 8 US Counties, 2016.

Jackson KA, Gokhale RH, Nadle J, Ray SM, Dumyati G, Schaffner W, Ham DC, Magill SS, Lynfield R, See I.

Clin Infect Dis. 2019 Apr 23. pii: ciz323. doi: 10.1093/cid/ciz323. [Epub ahead of print]

PMID:
31245810
3.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM; Emerging Infections Program MRSA author group, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D.

MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.

4.

Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013.

See I, Mu Y, Albrecht V, Karlsson M, Dumyati G, Hardy DJ, Koeck M, Lynfield R, Nadle J, Ray SM, Schaffner W, Kallen AJ.

Clin Infect Dis. 2019 Feb 25. pii: ciz158. doi: 10.1093/cid/ciz158. [Epub ahead of print]

PMID:
30801635
5.

Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.

Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, Wilson LE, Kainer MA, Lynfield R, Greissman S, Ray SM, Beldavs Z, Gross C, Bamberg W, Sievers M, Concannon C, Buhr N, Warnke L, Maloney M, Ocampo V, Brooks J, Oyewumi T, Sharmin S, Richards K, Rainbow J, Samper M, Hancock EB, Leaptrot D, Scalise E, Badrun F, Phelps R, Edwards JR; Emerging Infections Program Hospital Prevalence Survey Team.

N Engl J Med. 2018 Nov 1;379(18):1732-1744. doi: 10.1056/NEJMoa1801550.

PMID:
30380384
6.

Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections in Nursing Home Residents.

Grigg C, Palms D, Stone ND, Gualandi N, Bamberg W, Dumyati G, Harrison LH, Lynfield R, Nadle J, Petit S, Ray S, Schaffner W, Townes J, See I.

J Am Geriatr Soc. 2018 Aug;66(8):1581-1586. doi: 10.1111/jgs.15451. Epub 2018 Aug 10.

PMID:
30094828
7.

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs - Six Sites, 2005-2016.

Jackson KA, Bohm MK, Brooks JT, Asher A, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Schaffner W, Townes JM, See I.

MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):625-628. doi: 10.15585/mmwr.mm6722a2.

8.

Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014.

Gualandi N, Mu Y, Bamberg WM, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, McDonald M, See I.

Clin Infect Dis. 2018 Sep 28;67(8):1175-1181. doi: 10.1093/cid/ciy277.

9.

Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.

See I, Wesson P, Gualandi N, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Reisenauer C, Schaffner W, Tunali A, Mu Y, Ahern J.

Clin Infect Dis. 2017 Mar 1;64(5):597-604. doi: 10.1093/cid/ciw808.

10.

Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013.

Nguyen DB, See I, Gualandi N, Shugart A, Lines C, Bamberg W, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Njord L, Sievert D, Thompson ND, Patel PR.

Infect Control Hosp Epidemiol. 2016 Feb;37(2):205-7. doi: 10.1017/ice.2015.265. Epub 2015 Nov 11.

11.

Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013.

Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, Felsen C, Petit S, Yousey-Hindes K, Nadle J, Pasutti L, Lynfield R, Warnke L, Schaffner W, Leib K, Kallen AJ, Fridkin SK, Lessa FC.

Clin Infect Dis. 2016 Jan 1;62(1):45-52. doi: 10.1093/cid/civ777. Epub 2015 Sep 3.

12.

Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.

Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

JAMA. 2014 Oct 8;312(14):1438-46. doi: 10.1001/jama.2014.12923.

PMID:
25291579
13.

Multistate point-prevalence survey of health care-associated infections.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.

14.

Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.

Cohen J, Limbago B, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Phipps E, Beldavs Z, Clark LA, Lessa FC; CDC's Clostridium difficile Infection Surveillance Investigators.

J Clin Microbiol. 2014 Feb;52(2):632-4. doi: 10.1128/JCM.02177-13. Epub 2013 Nov 20.

15.

Trends in invasive methicillin-resistant Staphylococcus aureus infections.

Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC.

Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Review.

PMID:
24062373
16.

National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators.

JAMA Intern Med. 2013 Nov 25;173(21):1970-8. doi: 10.1001/jamainternmed.2013.10423.

PMID:
24043270
17.

Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011.

Nguyen DB, Lessa FC, Belflower R, Mu Y, Wise M, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Thompson J, Schaffner W, Patel PR; Active Bacterial Core Surveillance (ABCs) MRSA Investigators of the Emerging Infections Program.

Clin Infect Dis. 2013 Nov;57(10):1393-400. doi: 10.1093/cid/cit546. Epub 2013 Aug 19.

18.

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC; Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention.

Clin Infect Dis. 2013 Nov;57(9):1304-7. doi: 10.1093/cid/cit492. Epub 2013 Jul 29.

PMID:
23899677
19.

Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area.

Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, Pan E.

J Pediatric Infect Dis Soc. 2012 Sep;1(3):200-11. doi: 10.1093/jpids/pis061. Epub 2012 Jul 13.

20.

Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.

Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK; Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program.

Clin Infect Dis. 2012 Jul;55(2):232-41. doi: 10.1093/cid/cis408. Epub 2012 Apr 20.

PMID:
22523264
21.

Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype.

Satola SW, Lessa FC, Ray SM, Bulens SN, Lynfield R, Schaffner W, Dumyati G, Nadle J, Patel JB; Active Bacterial Core surveillance (ABCs) MRSA Investigators.

J Clin Microbiol. 2011 Apr;49(4):1583-7. doi: 10.1128/JCM.01719-10. Epub 2011 Feb 16.

22.

Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.

Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

Vaccine. 2009 Aug 13;27(37):5061-8. doi: 10.1016/j.vaccine.2009.06.055. Epub 2009 Jul 2.

PMID:
19576943
23.

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis.

Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

J Clin Microbiol. 2009 May;47(5):1344-51. doi: 10.1128/JCM.02264-08. Epub 2009 Mar 25.

24.

FoodNet survey of food use and practices in long-term care facilities.

Nelson JM, Bednarczyk R, Nadle J, Clogher P, Gillespie J, Daniels A, Plantenga M, Ingram A, Edge K, Furuno JP, Scallan E; FoodNet Emerging Infections Program Working Group.

J Food Prot. 2008 Feb;71(2):365-72.

PMID:
18326188
25.

Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators.

JAMA. 2007 Oct 17;298(15):1763-71.

PMID:
17940231
26.

Survey of clinical laboratory practices for parasitic diseases.

Jones JL, Lopez A, Wahlquist SP, Nadle J, Wilson M; Emerging Infections Program FoodNet Working Group.

Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S198-202.

PMID:
15095190
27.

Is drinking water a risk factor for endemic cryptosporidiosis? A case-control study in the immunocompetent general population of the San Francisco Bay Area.

Khalakdina A, Vugia DJ, Nadle J, Rothrock GA, Colford JM Jr.

BMC Public Health. 2003 Mar 7;3:11. Epub 2003 Mar 7.

28.

Active, multisite, laboratory-based surveillance for Cryptosporidium parvum.

Dietz V, Vugia D, Nelson R, Wicklund J, Nadle J, McCombs KG, Reddy S.

Am J Trop Med Hyg. 2000 Mar;62(3):368-72.

PMID:
11037779

Supplemental Content

Support Center